The possibility of a large epidemic of variant Creutzfeldt-Jakob disease cannot be excluded, and doctors may see patients who are worried about the possibility of this diagnosis. A study in this week's BMJ provides a comprehensive description of the early psychiatric and neurological features of variant Creutzfeldt-Jakob disease to aid early recognition of this condition.

Researchers analysed the case notes of the first 100 patients diagnosed with variant Creutzfeldt-Jakob disease in the UK.

They found that the early stages of variant Creutzfeldt-Jakob disease are dominated by psychiatric symptoms, such as dysphoria, withdrawal, anxiety, and insomnia. A significant proportion of patients also exhibit neurological symptoms within four months of clinical onset, including poor memory, pain, sensory symptoms, and unsteadiness of gait.

The early clinical features of variant Creutzfeldt-Jakob disease described in this paper are consistent with previous descriptions, say the authors. "We hope that the detailed analysis of the early psychiatric and neurological features of variant Creutzfeldt-Jakob disease in this paper may help with early and accurate recognition of this condition."

'"/>

Contact: Emma Wilkinson
ewilkinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
20-Jun-2002

Page: 1
Related medicine news :

1. Clinical breast examination offers modest benefit to breast cancer screening program
2. Clinical trial of Etanercept for Wegeners disease shows no benefit
3. Clinical trial participants fare no better, no worse than other patients
4. Clinical trial shows drug may offer a new option to prevent rejection of transplanted kidneys
5. National Academies news: Clinical research involving children
6. Clinical research key in advance to prospective health care
7. Clinical trial of new TB vaccine begins
8. Clinical trial of Alzheimers disease drug shows clear reductions in AD development
9. Clinical factors useful to identify heart failure patients with high risk of death
10. Panel: Clinical use of embryonic stem cells jeopardized by Bushs policy on federal funding
11. $7 million grant continues Asthma Clinical Research Network efforts